Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-28

Clinical Trial Update: Colchicine After Electrocardioversion for Atrial Fibrillation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the use of colchicine after electrical cardioversion for atrial fibrillation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Atrial Fibrillation, Cardiac Arrhythmia | Phase 3 | Status: RECRUITING